TargetMu-type opioid receptor(Homo sapiens (Human))
Temple University School Of Pharmacy
Curated by ChEMBL
Temple University School Of Pharmacy
Curated by ChEMBL
Affinity DataKi: 0.0100nMAssay Description:Binding affinity to mu opioid receptor (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0100nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0200nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0300nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0300nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0400nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0600nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0600nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0700nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0700nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0700nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.0900nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.110nMAssay Description:Inhibitory activity of the compound was measured against wild-type HIV-1 proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.120nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.130nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.130nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.160nMAssay Description:Inhibitory activity of the compound was measured against wild-type HIV-1 proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.170nMAssay Description:Inhibitory activity of the compound was measured against wild-type HIV-1 proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.260nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.270nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.310nMAssay Description:Inhibitory activity of the compound was measured against wild-type HIV-1 proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.400nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.400nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.450nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.450nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.470nMAssay Description:Inhibitory activity of the compound was measured against wild-type HIV-1 proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.5nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.620nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.680nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.800nMAssay Description:Inhibitory activity of the compound against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.850nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 0.850nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Inhibitory activity of the compound against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 1.5nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 1.70nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 2.40nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 2.5nMAssay Description:Inhibitory activity of the compound against HIV proteaseMore data for this Ligand-Target Pair
TargetDelta-type opioid receptor(Homo sapiens (Human))
Temple University School Of Pharmacy
Curated by ChEMBL
Temple University School Of Pharmacy
Curated by ChEMBL
Affinity DataKi: 3nMAssay Description:Binding affinity to delta opioid receptor (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 3nMAssay Description:Tested for inhibition of HIV protease using fluorogenic substrateMore data for this Ligand-Target Pair
Affinity DataKi: 3.5nMAssay Description:Displacement of [3H]DAMGO from mu opoid receptor in Dunkin-Hartley guinea pig brain after 1.5 hrs by liquid scintillation spectrometryMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 4.70nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 6.60nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetMu-type opioid receptor(Homo sapiens (Human))
Temple University School Of Pharmacy
Curated by ChEMBL
Temple University School Of Pharmacy
Curated by ChEMBL
Affinity DataKi: 7nMAssay Description:Binding affinity to mu opioid receptor (unknown origin)More data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Homo sapiens (Human))
Temple University School Of Pharmacy
Curated by ChEMBL
Temple University School Of Pharmacy
Curated by ChEMBL
Affinity DataKi: 7nMAssay Description:Binding affinity to kappa opioid receptor (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 7.20nMAssay Description:Displacement of [3H]DAMGO from mu opoid receptor in Dunkin-Hartley guinea pig brain after 1.5 hrs by liquid scintillation spectrometryMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 8nMAssay Description:Inhibitory activity of the compound against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Aids Drug Screening And Development Laboratory
Curated by ChEMBL
Affinity DataKi: 8.60nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair